News

OneTaq iPad2 winner

Leiden, October 31, 2011 - Last months we had a OneTaq Sample sample campaign. If you returned your data to us, you had the chance to win an iPad 2. On October 31, 2011 we draw the winner!

Read More
Academic Year Prize 2011

Leiden, October 10, 2011 - Creative scientists have a chance to win 100.000 Euros by presenting their research in an innovative and exciting way to a wide audience. Besides this Academic Year Prize, the nominees can win the Labyrint audience prize. You can vote for your favorite project until October 22, 2011.

Read More
Phusion DNA Polymerases still available from NEB

Leiden, May 9th, 2011 - Through NEB’s commitment to research and innovation, the Phusion products will now be manufactured at NEB and these products will also be available through BIOKÉ.

Read More
Webinar: Proteomics of Post-translational Modifications

Leiden, May 24th, 2011 – In association with Science, Cell Signaling Technology will organize a webinar on post-translational modifications (phosphorylation, acetylation, ubiquitination) on Wednesday June 8, 2011.

Read More
Fluidigm Introduces Fast 192.24 Dynamic Array™ IFC For Genotyping

Leiden, May 16th, 2011 – Fluidigm Corporation (NASDAQ:FLDM) today introduced its 192.24 Dynamic Array™ IFC, designed to genotype 192 samples against 24 SNP assays in a single run, providing 4,608 data points in just one hour.

Read More
Fluidigm launches low-cost assays

Leiden, May 9th, 2011 – Fluidigm launches low-cost assays for gene expression, SNP genotyping and target-specific primers for Next-Generation Sequencing.

Read More
NextGENe Challenge

Leiden, May 5th, 2011 - BIOKÉ and SoftGenetics are offering a free analysis of Next Generation Sequence data from the Roche FLX, Illumina GA or Life Technologies SOLiD system to illustrate the power and ease-of-use of NextGENe software.

BIOKÉ announces exclusive distribution agreement with New England Biolabs in the Benelux

Leiden, March 1st 2011 - BIOKÉ, a Cell Signaling Technology (CST) Europe company, announced today that it has entered into an exclusive distribution agreement in the Benelux countries, effective April 1st, 2011, with New England Biolabs.

Read More
Questionnaire

Leiden, January 20, 2011 - BIOKÉ is developing a quarterly newsletter and we want to know what you find important in this newsletter! Fill in this questionnaire and win 1 of the 5 BIO-CAKES for your lab!

Read More
Roche and Fluidigm Co-Promotion Agreement

Leiden, October 25, 2010 - Roche and Fluidigm Corporation Enter Worldwide Co-Promotion Agreement for 454 Sequencing Systems and Access Array Platform.

Read More
Signal Transduction Symposium

Leiden, October 12, 2010 - Join us at the Signal Transduction Symposium, Naturalis, Leiden. The symposium will bring together leading scientists to discuss developments and innovations in signal transduction research.

Meet us at HET Instrument 2010!

Leiden, September 1, 2010 - BIOKÉ will attend HET Instrument 2010 - the Sound of Technology! It is the only show of its size in the Benelux which concentrates on knowledge, technology and innovation for industry and science.

Read More
Free Analysis of Next Gen Sequence Data - Challenge us!

Leiden, March 1, 2010 - BIOKÉ and SoftGenetics are offering a free analysis of Next Generation Sequence data from the Roche FLX, Illumina GA or Life Technologies SOLiD system to illustrate the power and ease-of-use of NextGENe software.

Read More
Cell Signaling Technology Europe B.V. is now operating

Leiden, January 5, 2010 – Cell Signaling Technology Europe B.V. has started operations on January 1st, 2010.

Read More
New website including webshop!

Leiden, January 4, 2010 – BIOKÉ has launched a website with new features and enhancements. The website includes a webshop for convenient online ordering.

Read More
BIOKÉ has been acquired by Cell Signaling Technology

DANVERS, MA – July 9, 2009 – BIOKÉ has been renamed as Cell Signaling Technology Europe, B.V. and will become CST's base of operations in Europe.

Read More
China's Rujin Hospital uses Fluidigm to Validate New Risk Loci for Graves' Disease

South San Francisco, Calif. Oct. 3, 2011 - Fluidigm Corporation announced that China's Rujin Hospital in Shanghai has used the integrated fluidic circuits (IFCs) to help validate two new susceptibility loci for Graves' disease.

Read More
Webshop login
Create New Account
Password forgotten?